During #AIDS2024, Plus Life in partnership with Gilead Sciences produced a series of interviews. Here, Karl Schmid sits with Devi Sengupta, Exec. Director of Virology Therapeutic Area, to discuss why curing #HIV is so complex.
THE COMPLEXITY OF A CURE | Devi Sengupta
